Revolutionizing Cancer Therapy with Conditionally Active Biologics

Learn more Play Video

BioAtla® develops novel cancer therapeutics that meet critical needs including improved safety and the treatment of previously undruggable cancers.

Learn more

BioAtla® and Sinobioway Expand Collaboration Agreement and Enter Into Services Agreement

Learn more

We are Hiring!

At BioAtla® we recognize that the success of our business depends on the excellence of our people, and are dedicated to recruiting exceptional talent for our team.

Learn more

BioAtla mentioned in the media

Learn more

Conditionally Active Biologics (CAB’s)

BioAtla®’s revolutionary platform for developing conditionally active therapeutics yields antibodies (or other biologics) that can be activated or inactivated under defined physiological conditions.

Learn more

Tumor Microenvironment

Learn more